
Vol. 53, No. 1, 2007
Free Abstract Article (References)
Article (PDF 251 KB)
Review
Is Osteoarthritis an Infection-Associated Disease and a Target for Chemotherapy?
Alexander Rozin
B. Shine Department of Rheumatology, Rambam Medical Center, and B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
Address of Corresponding Author
Chemotherapy 2007;53:1-9 (DOI: 10.1159/000098243)
Key Words
- Osteoarthritis
- Cotrimoxazole
- Recurrent urinary tract infection
Abstract
The treatment of osteoarthritis (OA) continues to be a challenge, and current treatment modalities are disappointing. New approaches in therapy may be developed as a result of evidence of the involvement of inflammatory cytokines in the progression of OA. Cotrimoxazole (sulfamethoxazole/trimethoprim) was noted to have anti-inflammatory properties and has been used in the therapy of several autoimmune diseases. Analyzing our own and world experience, we propose that OA and degenerative joint and spine disease might be infection-associated diseases and a target for sulfamethoxazole/trimethoprim therapy. Copyright © 2007 S. Karger AG, Basel
Author Contacts Dr. Alexander Rozin Department of Rheumatology Rambam Medical Center, POB 9602 Haifa 31096 (Israel) Tel. +972 4 854 2268, Fax +972 4 854 2985, E-Mail a_rozin@ambam.health.gov.il
Article Information
Received: October 25, 2004
Accepted after revision: December 13, 2005
Published online: December 28, 2006
Number of Print Pages : 9
Number of Figures : 1, Number of Tables : 3, Number of References : 64 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|